TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma

<i>TMC5</i> and <i>SLC35F3</i> are promising biomarkers for TATCs in HCC, warranting further validation to explore their clinical and therapeutic implications.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioscience-Landmark
Published
2025-04-27
DOI
https://doi.org/10.31083/fbl36583
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma

Ying Xu, Jing Yu
Frontiers in Bioscience-Landmark
Cancer-related molecular mechanisms research
article

TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma

Ying Xu, Jing Yu
article en

Abstract

<i>TMC5</i> and <i>SLC35F3</i> are promising biomarkers for TATCs in HCC, warranting further validation to explore their clinical and therapeutic implications.

Frontiers in Bioscience-LandmarkVol. 30(4)
Shandong University (CN), Shandong Provincial Hospital (CN)
Natural Science Foundation of Shandong Province
Openalex Percentile: Top 88%
Cancer-related molecular mechanisms research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

TMC5 as a Marker of Tumor-Associated Telocytes in Hepatocellular Carcinoma — Ying Xu, Jing Yu · Frontiers in Bioscience-Landmark (2025) | TGRS Research Map | TGRS